Show simple item record

dc.rights.licenseAtribución-NoComercial 4.0 Internacional
dc.contributor.advisorGómez, Pio Iván
dc.contributor.authorHinojosa-Millán, Salomé
dc.contributor.authorFoliaco-Calderón, Natalia
dc.date.accessioned2020-01-20T14:52:58Z
dc.date.available2020-01-20T14:52:58Z
dc.date.issued2020-01-20
dc.date.issued2020-01-20
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/75496
dc.description.abstractObjective: assess the factors that influence contraceptive uptake among patients who undergo a voluntary termination of pregnancy in a private institution. Methods: Descriptive observational study, cohort type. Post-abortion contraception described as any contraception method provided during the first four weeks of the induced abortion. Prospective gathering of information supplied by clinical records and dispensary data. Inclusion criteria: women who interrupted their pregnancy voluntarily from 1st of January 2018 through 31ST of December 2018. Exclusion criteria: Women with cognitive deficit and incomplete data. Adjusted analysis was performed. Results: The total of patients included in the study were 5424. 90% of women left the facility with a contraceptive method. The majority (47.1%) selected a short-acting method. Women between 20 to 29 years old were more likely to choose a method than women 30 years or older (adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 1.01 – 1.5). Young women were also significantly more likely to choose a long-acting, reversible contraceptive than those ages 30 years or older (19 years: OR, 1.73; 95% CI, 1.4 to 2.4; 20–29 years: OR, 1.2; 95% CI, 1.1 to 1.5). Also, women with 18 weeks of pregnancy or longer (OR, 1.69; 95% CI, 1.08 to 2.6) and those who had a surgical abortion (OR, 1.5; 95% CI, 1.3 to 1.8). Conclusion: The majority of patients accepted a post abortion contraceptive method, mainly short-acting methods. Being between 20 and 29 years old was associated with accepting any type of contraception, the use of long-term contraceptives was associated with surgical abortion.
dc.description.abstractObjetivo: Evaluar factores que influyen en el inicio de un método anticonceptivo posterior a una interrupción voluntaria del embarazo en una clínica privada de Bogotá. Métodos: Estudio descriptivo observacional, tipo cohorte. Anticoncepción postaborto definida como la suministrada dentro de las 4 semanas posteriores al aborto. Recolección prospectiva de información, mediante historia clínica y datos del dispensario. Criterios de inclusión: Mujeres en quienes se realizó una interrupción voluntaria de embarazo entre 1 enero de 2018 y 31 de diciembre de 2018. Criterios de exclusión: Mujeres con déficit cognoscitivo y datos incompletos. Se realizó análisis ajustado. Resultados: Se incluyeron 5424 pacientes, 90% aceptó algún método anticonceptivo. La mayoría (47,1%) seleccionaron un método de acción corta. Las mujeres entre 20 a 29 años tenían más probabilidades de elegir un método anticonceptivo en comparación con las mayores de 30 años (odds ratio ajustado [aOR] 1.24; intervalo de confianza [IC] del 95%, (1.01 – 1.5)). Las mujeres menores de 30 años fueron más propensas a elegir un anticonceptivo de acción prolongada (≤19 años: OR 1.73; IC del 95%, (1.4-2.4); 20-29 años: OR, 1.3; IC 95%, (1.1 -1.5), también las mujeres con embarazos mayores a 18 semanas (OR 1.69; [IC] del 95%, (1,08 – 2.6) y con aborto quirúrgico (OR 1.5; [IC] del 95%, (1.3 – 1.8). Conclusión: La mayoría aceptó algún método de anticonceptivo postaborto, principalmente métodos de corta acción. Tener entre 20 y 29 años se asoció al uso de algún tipo de anticoncepción, el uso de anticonceptivos de larga duración se asoció al aborto quirúrgico.
dc.format.extent56
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rightsDerechos reservados - Universidad Nacional de Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddcMedicina y salud::Ginecología, obstetricia, pediatría, geriatría
dc.title¿Qué factores contribuyen a la aceptación de un método anticonceptivo posterior a una Interrupción Voluntaria del embarazo en una institución privada del país?
dc.title.alternativeWhat factors contribute to the acceptance of a method contraceptive after a Voluntary Interruption of pregnancy in a private institution ?
dc.typeDocumento de trabajo
dc.rights.spaAcceso abierto
dc.coverage.sucursalUniversidad Nacional de Colombia - Sede Bogotá
dc.type.driverinfo:eu-repo/semantics/other
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.contributor.researchgroupSALUD SEXUAL Y REPRODUCTIVA
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.references1. Gómez I, Urquijo L, Villarreal C. Estrategia FIGO para la prevención del aborto inseguro, experiencia en Colombia. Rev Colomb Obstet y Ginecol. 2011;62(1):24–35.
dc.relation.references2. Corte Constitucional de Colombia. Sentencia C-355 de 2006. Bogotá. 2006. Available from: http://www.alcaldiabogota.gov.co/sisjur/normas/Norma1.jsp?i=21540
dc.relation.references3. Samuel M, Fetters T, Desta D. Strengthening Postabortion Family Planning Services in Ethiopia: Expanding Contraceptive Choice and Improving Access to Long-Acting Reversible Contraception. Glob Heal Sci Pract. The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. 2016;4 (Suppl 2):S60-72.
dc.relation.references4. MINISTERIO DE SALUD Y PROTECCIÓN SOCIAL. Atención Post Aborto (APA) y sus complicaciones. Bogotá. 2014.
dc.relation.references5. Marrs RP, Kletzky OA, Howard WF, Mishell DR. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol. Mosby; 1979;135(6):731–6.
dc.relation.references6. Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84(3):230–3.
dc.relation.references7. World Health Organization. Safe abortion: technical and policy guidance for health systems Second edition technical and policy guidance for health systems. 2012. Available from: www.who.int/reproductivehealth
dc.relation.references8. Bitzer J, Gemzell-Danielsson K, Roumen F, Marintcheva-Petrova M, van Bakel B, Oddens BJ. The CHOICE study: Effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Heal Care. 2012;17(1):65–78.
dc.relation.references9. Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception. 2008;78(2):143–8.
dc.relation.references10. Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206(1):37.e1-37.e6.
dc.relation.references11. Reeves MF, Smith KJ, Creinin MD. Contraceptive Effectiveness of Immediate Compared With Delayed Insertion of Intrauterine Devices After Abortion. Obstet Gynecol. 2007;109(6):1286–94.
dc.relation.references12. Salcedo J, Sorensen A, Rodriguez MI. Cost analysis of immediate postabortal IUD insertion compared to planned IUD insertion at the time of abortion follow up. Contraception. 2013 ;87(4):404–8.
dc.relation.references13. Vayssière C, Gaudineau A, Attali L, Bettahar K, Eyraud S, Faucher P, et al. Elective abortion: Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2018;222:95–101.
dc.relation.references14. Huber D, Curtis C, Irani L, Pappa S, Arrington L. Postabortion Care: 20 Years of Strong Evidence on Emergency Treatment, Family Planning, and Other Programming Components. Glob Heal Sci Pract. Global Health: Science and Practice; 2016;4(3):481–94.
dc.relation.references15. Alemayehu T, Hendrickson C, Brahmi D, Desta D, Fetters T. An evaluation of postabortion contraceptive uptake following a youth-friendly service intervention in Ethiopia. Contraception. 2013;88(3):447–8.
dc.relation.references16. Foundation LU and B& MG. London Summit on Family Planning. Summ commitments. 2012.
dc.relation.references17. Prada E, MaddowZimet I, Fátima Y, Juárez. El costo de la atención postaborto y del aborto legal en Colombia. Perspect Int en Salud Sex y Reprod. 2014;2–12.
dc.relation.references18. Benson J, Andersen K, Healy J, Brahmi D. What Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan Africa. Glob Heal Sci Pract. The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs; 2017;5(4):644–57.
dc.relation.references19. Ministerio de Salud y Protección Social. Profamilia. Encuesta Nacional de Demografía y Salud. Situación los Niños y Niñas en Colomb. 2016;430.
dc.relation.references20. Amado ED, Calderón García MC, Cristancho KR, Salas EP, Hauzeur EB. Obstacles and challenges following the partial decriminalisation of abortion in Colombia. Reprod Health Matters. 2010;18(36):118–26.
dc.relation.references21. Prada E, Singh S, Remez L, Villarreal C. Embarazo no deseado y aborto inducido en Colombia: causas y consecuencias. Nueva York Guttmacher Institute. 2011. Available from: https://www.guttmacher.org/sites/default/files/report_pdf/embarazo-no-deseado-colombia_1.pdf
dc.relation.references22. Laursen L, Stumbras K, Lewnard I, Haider S. Contraceptive Provision after Medication and Surgical Abortion. Women’s Heal Issues. 2017;27(5):546–50.
dc.relation.references23. Profamilia. Informe Anual de Actividadades 2017. Colombia; 2017.
dc.relation.references24. High Impact Practices in Family Planning (HIP). Postabortion family planning: a critical component of postabortion care. Washington, DC: USAID; 2019. Available from: https://www.fphighimpactpractices.org/briefs/postabortion-family-planning/
dc.relation.references25. Teen Abortions - Child Trends. 2018. Available from: https://www.childtrends.org/indicators/teen-abortions
dc.relation.references26. Sedgh G, Bankole A, Singh S, Eilers M. Legal Abortion Levels and Trends By Woman’s Age at Termination. Int Perspect Sex Reprod Health. 2012;38(3):143–53.
dc.relation.references27. Aborto sin riesgos: guía técnica y de políticas para sistemas de salud – 2ª ed. Organización Mundial de la Salud, 2012.
dc.relation.references28. CONGRESO DE LA REPÚBLICA. Ley 1090 de 2006. Colombia. 2006. Available from: https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=66205
dc.relation.references29. Biney AAE, Atiglo DY. Examining the association between motivations for induced abortion and method safety among women in Ghana. Women Health. 2017;57(9):1044–60.
dc.relation.references30. Singh N, Shukla S. Does violence affect the use of contraception? Identifying the hidden factors from rural India. J Fam Med Prim Care. Medknow; 2017;6(1):73.
dc.relation.references31. Insurance Coverage of Contraceptives. Guttmacher Institute. 2019. Available from: https://www.guttmacher.org/state-policy/explore/insurance-coverage-contraceptives
dc.relation.references32. Benson J, Andersen K, Healy J, Brahmi D. What Factors Contribute to Postabortion Contraceptive Uptake By Young Women? A Program Evaluation in 10 Countries in Asia and sub-Saharan Africa. Glob Heal Sci Pract. 2017;5(4):644–57.
dc.relation.references33. Rivas AT. Prevenir y educar: sobre la historia de la educación sexual en Colombia. Praxis & Saber. 2017; 8 (17).
dc.relation.references34. Ezeh AC. The influence of spouses over each other’s contraceptive attitudes in Ghana. Stud Fam Plann. 1993;24(3):163–74.
dc.relation.references35. Benson J, Andersen K, Brahmi D, Healy J, Mark A, Ajode A, et al. Global Public Health An International Journal for Research, Policy and Practice What contraception do women use after abortion? An analysis of 319,385 cases from eight countries. Public Health. 2016;13(1):35–50.
dc.relation.references36. Benson J, Andersen K, Brahmi D, Healy J, Mark A, Ajode A, et al. What contraception do women use after abortion? An analysis of 319,385 cases from eight countries. Glob Public Health. 2018;13(1):35–50.
dc.relation.references37. Goyal V, Canfield C, Aiken ARA, Dermish A, Potter JE. Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free. Obstet Gynecol. 2017;129(4):655–62.
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.proposalAborto inducido, Anticoncepción, Anticoncepción Reversible de Larga Duración
dc.subject.proposalAbortion, Induced, Contraception, Long-Acting Reversible Contraception.
dc.type.coarhttp://purl.org/coar/resource_type/c_1843
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.contentText
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial 4.0 InternacionalThis work is licensed under a Creative Commons Reconocimiento-NoComercial 4.0.This document has been deposited by the author (s) under the following certificate of deposit